Vimarsana
Biggest News Aggregation in the World

Page 30 - Fda Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approval Today - Breaking & Trending Today

Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors - Vimarsana News

Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors

/PRNewswire/ -- Harbour BioMed (the"Company", HKEX: 02142) announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug...

FDA Approves Natalizumab Biosimilar, First for Multiple Sclerosis - Vimarsana News

FDA Approves Natalizumab Biosimilar, First for Multiple Sclerosis

The FDA has approved the first biosimilar to treat multiple sclerosis, Sandoz's injection treatment natalizumab-sztn (Tyruko).

Source: ajmc.com
FDA Approves RSV Vaccine for Pregnant Individuals to Prevent Virus in Infants - Vimarsana News

FDA Approves RSV Vaccine for Pregnant Individuals to Prevent Virus in Infants

The respiratory syncytial virus (RSV) vaccine Abrysvo is approved for use in pregnant individuals to prevent the RSV in infants up to 6 months of age.

Source: ajmc.com
How fifth circuit court of appeals mifepristone ruling pokes holes in wider FDA authority - Vimarsana News

How fifth circuit court of appeals mifepristone ruling pokes holes in wider FDA authority

By questioning the FDA's authority to regulate an abortion drug, the courts undermine its authority to regulate all medications, legal experts say.

Source: yahoo.com
Appeals court upholds some restrictions on abortion pill mifepristone - Vimarsana News

Appeals court upholds some restrictions on abortion pill mifepristone

A federal appeals court on Wednesday ruled to restrict some access to the abortion pill mifepristone, partially keeping a lower court ruling intact that would fully revoke federal approval.